Rogers JT - Search Results

1

Functional characterization of three single-nucleotide polymorphisms present in the human APOE promoter sequence: Differential effects in neuronal cells and on DNA-protein interactions.

Maloney B, Ge YW, Petersen RC, Hardy J, Rogers JT, Pérez-Tur J, Lahiri DK. Maloney B, et al. Among authors: rogers jt. Am J Med Genet B Neuropsychiatr Genet. 2010 Jan 5;153B(1):185-201. doi: 10.1002/ajmg.b.30973. Am J Med Genet B Neuropsychiatr Genet. 2010. PMID: 19504470 Free PMC article.

2

Phenserine regulates translation of beta -amyloid precursor protein mRNA by a putative interleukin-1 responsive element, a target for drug development.

Shaw KT, Utsuki T, Rogers J, Yu QS, Sambamurti K, Brossi A, Ge YW, Lahiri DK, Greig NH. Shaw KT, et al. Proc Natl Acad Sci U S A. 2001 Jun 19;98(13):7605-10. doi: 10.1073/pnas.131152998. Epub 2001 Jun 12. Proc Natl Acad Sci U S A. 2001. PMID: 11404470 Free PMC article.

3

An iron-responsive element type II in the 5'-untranslated region of the Alzheimer's amyloid precursor protein transcript.

Rogers JT, Randall JD, Cahill CM, Eder PS, Huang X, Gunshin H, Leiter L, McPhee J, Sarang SS, Utsuki T, Greig NH, Lahiri DK, Tanzi RE, Bush AI, Giordano T, Gullans SR. Rogers JT, et al. J Biol Chem. 2002 Nov 22;277(47):45518-28. doi: 10.1074/jbc.M207435200. Epub 2002 Aug 26. J Biol Chem. 2002. PMID: 12198135 Free article.

4

Alzheimer's disease drug discovery targeted to the APP mRNA 5'untranslated region.

Rogers JT, Randall JD, Eder PS, Huang X, Bush AI, Tanzi RE, Venti A, Payton SM, Giordano T, Nagano S, Cahill CM, Moir R, Lahiri DK, Greig N, Sarang SS, Gullans SR. Rogers JT, et al. J Mol Neurosci. 2002 Aug-Oct;19(1-2):77-82. doi: 10.1007/s12031-002-0014-6. J Mol Neurosci. 2002. PMID: 12212798

5

Role of cytokines in the gene expression of amyloid beta-protein precursor: identification of a 5'-UTR-binding nuclear factor and its implications in Alzheimer's disease.

Lahiri DK, Chen D, Vivien D, Ge YW, Greig NH, Rogers JT. Lahiri DK, et al. Among authors: rogers jt. J Alzheimers Dis. 2003 Apr;5(2):81-90. doi: 10.3233/jad-2003-5203. J Alzheimers Dis. 2003. PMID: 12719626

6

Thalidomide-based TNF-alpha inhibitors for neurodegenerative diseases.

Greig NH, Giordano T, Zhu X, Yu QS, Perry TA, Holloway HW, Brossi A, Rogers JT, Sambamurti K, Lahiri DK. Greig NH, et al. Among authors: rogers jt. Acta Neurobiol Exp (Wars). 2004;64(1):1-9. doi: 10.55782/ane-2004-1486. Acta Neurobiol Exp (Wars). 2004. PMID: 15190675 Free article.

7

Metal and inflammatory targets for Alzheimer's disease.

Rogers JT, Lahiri DK. Rogers JT, et al. Curr Drug Targets. 2004 Aug;5(6):535-51. doi: 10.2174/1389450043345272. Curr Drug Targets. 2004. PMID: 15270200 Review.

8

Rationale for the development of cholinesterase inhibitors as anti-Alzheimer agents.

Lahiri DK, Rogers JT, Greig NH, Sambamurti K. Lahiri DK, et al. Among authors: rogers jt. Curr Pharm Des. 2004;10(25):3111-9. doi: 10.2174/1381612043383331. Curr Pharm Des. 2004. PMID: 15544501 Review.

9

The integrated role of desferrioxamine and phenserine targeted to an iron-responsive element in the APP-mRNA 5'-untranslated region.

Venti A, Giordano T, Eder P, Bush AI, Lahiri DK, Greig NH, Rogers JT. Venti A, et al. Among authors: rogers jt. Ann N Y Acad Sci. 2004 Dec;1035:34-48. doi: 10.1196/annals.1332.003. Ann N Y Acad Sci. 2004. PMID: 15681799

10

Melatonin, metals, and gene expression: implications in aging and neurodegenerative disorders.

Lahiri DK, Chen D, Lahiri P, Rogers JT, Greig NH, Bondy S. Lahiri DK, et al. Among authors: rogers jt. Ann N Y Acad Sci. 2004 Dec;1035:216-30. doi: 10.1196/annals.1332.014. Ann N Y Acad Sci. 2004. PMID: 15681810 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

150 results

Search Page

Filters